跳至主要内容
临床试验/NCT00392145
NCT00392145已完成4 期

Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis: A Randomized Controlled Trial

The Hospital for Sick Children1 个研究点 分布在 1 个国家目标入组 226 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
226
试验地点
1
主要终点
Rehydration criteria defined by: dehydration score ≤ 1, normal capillary refill time, normal skin turgor, normal respiratory rate

研究概览

简要总结

This study will look at children with dehydration secondary to gastroenteritis requiring IV rehydration and determine whether the proportion rehydrated after two hours is greater in the children who receive rapid intravenous rehydration (RIVR) or in the children who receive standard IV rehydration.

详细描述

Despite a movement toward increased use of enteral rehydration, many children still receive prolonged IV rehydration in the emergency department (ED). These children commonly receive a single IV bolus of normal saline followed by the administration of a hypotonic solution at a maintenance rate.

The mean time spent in the ED by children receiving IV rehydration is significantly longer than the mean time required to treat all other conditions. ED overcrowding has been associated with poor outcomes, prolonged pain and suffering, and dissatisfaction. One of the solutions proposed in the American Academy of Pediatrics Policy Statement on ED overcrowding is that hospitals should strive to improve the efficiency of the care provided. One small step in this direction may be to improve our management of gastroenteritis and dehydration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
90 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Acute gastroenteritis as determined by the supervising physician.
  • Age greater than 90 days
  • Dehydrated and unable to consume sufficient oral fluids to overcome their dehydration state

排除标准

  • Weight less than 5 kg or greater than 33 kg
  • Underlying disease which may limit the amount of IV fluids given,including but not limited to: hypoalbuminemic states, renal insufficiency, heart disease requiring pharmacotherapy or lesions that may predispose to congestive heart failure, hypertension, chronic lung disease (excluding asthma), diabetes mellitus, severe anemia, and chronic inflammatory disease
  • Clinical suspicion by the attending physician of myocarditis or previously undiagnosed cardiac or renal disease.
  • History of abdominal surgery or concern regarding an acute surgical abdomen
  • Significant head, chest or abdominal trauma within the preceding 7 days
  • Bilious or bloody vomitus
  • Evidence of hemodynamic compromise (BP < 80 + 2 * age (yrs)) requiring > 20 mL/kg 0.9% normal saline to be administered in the 1st hour
  • Bedside glucose < 2.8 mmol/L (see Section 8.3)
  • Unable to provide a telephone number or unavailable for follow-up
  • Previously enrolled in this trial

研究组 & 干预措施

1

Active Comparator

干预措施: Standard IV rehydration (Drug)

2

Experimental

干预措施: Rapid intravenous rehydration (RIVR) (Drug)

结局指标

主要结局

Rehydration criteria defined by: dehydration score ≤ 1, normal capillary refill time, normal skin turgor, normal respiratory rate

时间窗: 2 hours following the initiation of IV rehydration

次要结局

  • Hospitalization(72 hours)
  • Repeat ED visit(72 hours)
  • Attending physician discharge comfort level(Two and four hours following initiation of IV rehydration)
  • Ability to tolerate oral rehydration(Measured per 2 hour time period after consuming 5 mL/kg of liquid)
  • Time (in minutes) from initiation of IV rehydration until disposition determination(Determined by outcome)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen Freedman

Adjunct Scientist

The Hospital for Sick Children

研究点 (1)

Loading locations...

相似试验